Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06129747 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor 3 versions Re-verified since May 6, 2026, no change to tracked fieldsv9-v11
  2. Minor Eligibility criteria expanded, about 48 wordsv8
  3. Minor Re-verified, no change to tracked fieldsv7
  4. Minor Eligibility criteria shortened, about 36 words
    • Site contacts updated at 1 of 2 sites
    v6
  5. Minor Site details revised at 1 of 2 sitesv5
Show 3 earlier versionsHide 3 earlier versions
  1. Minor Study sites: 1 to 2v4
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 22, 2023 to Nov 30, 2023
    • Site details revised
    v3
  3. Minor Study description shortened, about 21 wordsv2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The standard treatment for participants whose cancer has returned after breast conserving surgery is radiation given twice daily (separated by at least 6 hours) for a total of 30 treatments. The purpose of this study is to find out if giving radiation once a day for 15 treatments after repeat breast conserving surgery works as well as giving it the standard way.
Trial Details
NCT Number NCT06129747
Lead Sponsor Case Comprehensive Cancer Center
Conditions
(from sponsor)
Breast Cancer, Tumor, Breast
Related terms Breast Neoplasms, Neoplasms
Enrollment 55 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov